PAVmed CEO to Present at 2016 Marcum MicroCap Conference on June 2, 2016

Thursday, May 26, 2016 4:05 pm EDT

Dateline:

NEW YORK

Public Company Information:

NASDAQ:
PAVMU

NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq:PAVMU), an innovative, multi-product medical device company developing and commercializing a diversified pipeline of innovative products utilizing a groundbreaking business model focused on capital efficiency and speed to market, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present at the 2016 Marcum MicroCap Conference on Thursday, June 2, 2016, at 3:30pm ET taking place in New York City. Dr. Aklog will provide a corporate overview, discuss the company’s innovative business model and review PAVmed’s five lead products.

To access the live webcast of the presentation, please click here. A replay will be available following the presentation.

About PAVmed

PAVmed Inc. is an innovative, multi-product medical device company developing and commercializing a diversified pipeline of innovative products which address unmet clinical needs. The Company’s goal is to enhance and accelerate value creation by employing a business model focused on capital efficiency and speed to market. PAVmed is building a deep development product pipeline with attractive regulatory pathways and market opportunities encompassing a broad spectrum of clinical areas including carpal tunnel syndrome, medical infusions, interventional radiology, tissue ablation, and cardiovascular intervention. The Company is further expanding its pipeline through engagements with clinician innovators and leading academic medical centers.

Forward-Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, based upon the current beliefs and expectations of the Company’s management, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements.

Contact:

For PAVmed:
Investors:
Matthew Ventimiglia, 212-599-1265
mventimiglia@lazarpartners.com
or
Media:
Erich Sandoval, 213-908-6226
esandoval@lazarpartners.com

SEC Filings

Click Here to view PAVmed's SEC filings

INVESTOR PRESENTATION

Click Here to view PAVmed’s current Investor Presentation

PROXY MATERIALS

Click Here to view the Proxy Statement for PAVmed Inc 2018 Annual Meeting

Click Here to view the Annual Report for PAVmed Inc 2018 Annual Meeting